Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Third Harmonic Bio Inc (THRD)

Third Harmonic Bio Inc (THRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Third Harmonic Bio Inc 1700 MONTGOMERY STREET SUITE 210 SAN FRANCISCO CA 94111 USA

www.thirdharmonicbio.com P: 209-727-2457

Description:

Third Harmonic Bio Inc. is a clinical-stage biopharmaceutical company focused on advancing the next wave of medicine for allergy and inflammation. The company's principal candidate includes THB001, is a highly selective, oral small-molecule inhibitor of KIT. Third Harmonic Bio Inc. is based in CAMBRIDGE, Mass.

Key Statistics

Overview:

Market Capitalization, $K 472,374
Enterprise Value, $K 203,304
Shares Outstanding, K 40,757
Annual Sales, $ 0 K
Annual Net Income, $ -30,820 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -6,840 K
EBIT, $ -43,960 K
EBITDA, $ -43,920 K
60-Month Beta 2.86
% of Insider Shareholders 5.90%
% of Institutional Shareholders 93.95%
Float, K 38,352
% Float 94.10%
Short Volume Ratio 0.88

Growth:

1-Year Return 140.25%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.17 on 03/26/24
Latest Earnings Date 05/09/24 [--]
Earnings Per Share ttm -0.61
EPS Growth vs. Prev Qtr 189.47%
EPS Growth vs. Prev Year 147.22%
Annual Dividend Yield 0.00%
Next Ex-Dividends Date 08/06/14
Dividend Payout Ratio 0.00%

THRD Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -6.22%
Return-on-Assets % -6.03%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.67
Book Value/Share 6.67
Interest Coverage -0.54
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar